WEDNESDAY APRIL 23rd RACING POST 2014.

WEDNESDAY APRIL 23rd RACING POST CH4 
WEEK MONDAY APRIL 21st TO SUNDAY APRIL 27th

ENTRIES ... PREVIEW RACE DAY CLUES  .... RACE DAY ACTION …. REVIEW RACE DAY ACTION.

There are a lot of people who tell you they can ride. But few belong in the Equus Zone.

http://turfcallmorningline.blogspot.co.uk/2014/04/easter-saturday-april-19-2014-ch4.html  

 PREVIEW TODAY'S EQUUS CARDS 

 http://www.racingpost.com/horses2/cards/home.sd 

http://www.racingpost.com/news/liv
*  REVIEW YESTERDAY'S EQUUS  RESULTS   *

http://www.racingpost.com/horses2/results/home.sd?r_date=2014-04-22  

CHANNEL 4 LIVE HORSERACING

    http://racing.channel4.com/   
 EQUUS BIG  RACE ENTRIES  

http://www.racingpost.com/horses2/cards/big_races.sd 
INTERNATIONAL HORSERACING (media) NEWS

  Nicholas Godfrey (GB) (RP)   

 (Horseracing Global Media Zone)


BBC1 BREAKFAST

Bill Turnbull and Louise Minchin

It’s not only the British political and horseracing government in a confused state over which medication can be needed  and used for the four legged variety, Similar same applies for two legged variety we find as the BBC1 Breakfast Team take a closer look at the cost of new cancer drug Cadcyla  £90,000 per person? What planet are we on? Is anyone allowed to know?

 

NICE questions cost of medicines development - PMLiVE

http://www.pmlive.com/pharma_news/nice_questions_cost_of_medicines_development_501375

6 Sep 2013 ... “If it really does cost £1.2bn to develop a new drug, the question the ... kindly to Sir Andrew's letter, with Stephen Whitehead, chief executive of trade body the ... invest heavily to discover valuable medicines for diseases such as cancer, ... J&J files 'breakthrough' drug ibrutinib in US · AstraZeneca buys BMS ...

 

VBP - PMLiVE   

http://www.pmlive.com/tags/vbp%3Ftag%3DVBP

The way prices for new drugs are negotiated in the UK is currently under review with a new ... Charity says patients worried about Cancer Drugs Fund's future ... of value-based pricing ( VBP) for new medicines is set to replace the current Pharmaceutical Price Regulation Scheme ( ... Interview: Stephen Whitehead, ABPI.